Mark D. Berry

2.9k total citations
51 papers, 2.3k citations indexed

About

Mark D. Berry is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, Mark D. Berry has authored 51 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Cellular and Molecular Neuroscience and 6 papers in Cell Biology. Recurrent topics in Mark D. Berry's work include Neuroscience and Neuropharmacology Research (9 papers), Receptor Mechanisms and Signaling (9 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Mark D. Berry is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Receptor Mechanisms and Signaling (9 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Mark D. Berry collaborates with scholars based in Canada, Switzerland and United Kingdom. Mark D. Berry's co-authors include Marius C. Hoener, Raul R. Gainetdinov, A. V. Juorio, Paula Ashe, I.A. Paterson, A. A. Boulton, Mohammed Shahid, Alan A. Boulton, Andrew Riches and Meng‐Yang Zhu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Pharmacological Reviews.

In The Last Decade

Mark D. Berry

49 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Berry Canada 23 1.1k 951 206 202 146 51 2.3k
Akira Katoh Japan 34 1.5k 1.4× 1.0k 1.1× 106 0.5× 187 0.9× 199 1.4× 174 3.7k
Wolfgang Jarolimek Australia 26 1.8k 1.6× 1.5k 1.6× 88 0.4× 269 1.3× 105 0.7× 60 3.2k
Yoshitatsu Sei United States 31 1.4k 1.3× 666 0.7× 96 0.5× 315 1.6× 100 0.7× 78 3.0k
Antonello Novelli Spain 26 1.5k 1.4× 1.7k 1.8× 297 1.4× 581 2.9× 108 0.7× 75 3.2k
M.A.A. Namboodiri United States 37 1.8k 1.6× 1.5k 1.6× 211 1.0× 584 2.9× 161 1.1× 76 4.9k
Francisco Capani Argentina 32 1.2k 1.1× 615 0.6× 364 1.8× 486 2.4× 208 1.4× 123 3.3k
Mark J. Wall United Kingdom 30 1.5k 1.3× 1.2k 1.2× 127 0.6× 265 1.3× 150 1.0× 97 3.0k
Alexander Zharkovsky Estonia 29 1.1k 1.0× 1.1k 1.2× 261 1.3× 397 2.0× 130 0.9× 99 2.7k
Moo Ho Won South Korea 35 1.7k 1.5× 1.3k 1.4× 195 0.9× 621 3.1× 222 1.5× 166 3.9k
Paul McGonigle United States 29 1.5k 1.4× 1.7k 1.8× 275 1.3× 372 1.8× 91 0.6× 59 3.1k

Countries citing papers authored by Mark D. Berry

Since Specialization
Citations

This map shows the geographic impact of Mark D. Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Berry more than expected).

Fields of papers citing papers by Mark D. Berry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Berry. The network helps show where Mark D. Berry may publish in the future.

Co-authorship network of co-authors of Mark D. Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Berry. A scholar is included among the top collaborators of Mark D. Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Berry. Mark D. Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumari, Sarika, et al.. (2024). Polyphenols from unconventional fruit by-products protect human epithelial intestinal cells from oxidative damage. Food Bioscience. 62. 105302–105302. 1 indexed citations
2.
Bambico, Francis Rodriguez, Mark D. Berry, Qi Yuan, et al.. (2023). A short pre-conception bout of predation risk affects both children and grandchildren. Scientific Reports. 13(1). 10886–10886.
3.
Hoener, Marius C., et al.. (2022). TAAR1 Regulates Purinergic-induced TNF Secretion from Peripheral, But Not CNS-resident, Macrophages. Journal of Neuroimmune Pharmacology. 18(1-2). 100–111. 3 indexed citations
4.
Galloway, Dylan A., et al.. (2021). TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation. International Journal of Molecular Sciences. 22(21). 11576–11576. 18 indexed citations
5.
6.
Bagnati, Marta, T. Alwyn Jones, Babatunji W Ogunkolade, et al.. (2019). Identification of a subset of trace amine-associated receptors and ligands as potential modulators of insulin secretion. Biochemical Pharmacology. 171. 113685–113685. 13 indexed citations
7.
Berry, Mark D., Raul R. Gainetdinov, Marius C. Hoener, & Mohammed Shahid. (2017). Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges. Pharmacology & Therapeutics. 180. 161–180. 166 indexed citations
8.
Jones, J. Gareth, Ronald F. Grossman, Mark D. Berry, et al.. (2015). Alveolar-Capillary Membrane Permeability. American Review of Respiratory Disease.
9.
Berry, Mark D., et al.. (2015). A Permeability Study of O2 and the Trace Amine p-Tyramine through Model Phosphatidylcholine Bilayers. PLoS ONE. 10(6). e0122468–e0122468. 12 indexed citations
10.
Berry, Mark D., et al.. (2013). Membrane permeability of trace amines: Evidence for a regulated, activity-dependent, nonexocytotic, synaptic release. Synapse. 67(10). 656–667. 26 indexed citations
11.
Berry, Mark D.. (2007). The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases. Reviews on Recent Clinical Trials. 2(1). 3–19. 92 indexed citations
12.
Berry, Mark D.. (2004). Dynamic molecular resolution imaging of preocular fluid impressions. British Journal of Ophthalmology. 88(11). 1460–1466. 8 indexed citations
13.
Berry, Mark D.. (2004). Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. Journal of Neurochemistry. 90(2). 257–271. 289 indexed citations
14.
Berry, Mark D.. (2004). Human preocular mucins reflect changes in surface physiology. British Journal of Ophthalmology. 88(3). 377–383. 36 indexed citations
15.
Berry, Mark D. & A. A. Boulton. (2002). Aliphatic propargylamines as symptomatic and neuroprotective treatments for neurodegenerative diseases. Neurotoxicology and Teratology. 24(5). 667–673. 14 indexed citations
16.
Round, Andrew N., Mark D. Berry, Terence J McMaster, et al.. (2002). Heterogeneity and Persistence Length in Human Ocular Mucins. Biophysical Journal. 83(3). 1661–1670. 82 indexed citations
17.
Berry, Mark D.. (1999). N8-acetyl spermidine protects rat cerebellar granule cells from low K+-induced apoptosis. Journal of Neuroscience Research. 55(3). 341–351. 8 indexed citations
18.
Berry, Mark D., et al.. (1996). Aromaticl-amino acid decarboxylase: A neglected and misunderstood enzyme. Neurochemical Research. 21(9). 1075–1087. 98 indexed citations
19.
Berry, Mark D., A. V. Juorio, & I.A. Paterson. (1994). Possible mechanisms of action of (−)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders. Progress in Neurobiology. 44(2). 141–161. 44 indexed citations
20.
Larkin, Frank, J. K. G. Dart, Simon Kilvington, & Mark D. Berry. (1991). TREATMENT OF ACANTHAMOEBA KERATITIS WITH POLYHEXAMETHYLENE BIGUANIDE. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akira Katoh Breakdown of academic impact, for papers by Wolfgang Jarolimek Breakdown of academic impact, for papers by Yoshitatsu Sei Breakdown of academic impact, for papers by Antonello Novelli Breakdown of academic impact, for papers by M.A.A. Namboodiri Breakdown of academic impact, for papers by Francisco Capani Breakdown of academic impact, for papers by Mark J. Wall Breakdown of academic impact, for papers by Alexander Zharkovsky Breakdown of academic impact, for papers by Moo Ho Won Breakdown of academic impact, for papers by Paul McGonigle
Rankless by CCL
2026